Disruption of HAUSP gene stabilizes p53

被引:0
|
作者
Jordan M. Cummins
Carlo Rago
Manu Kohli
Kenneth W. Kinzler
Christoph Lengauer
Bert Vogelstein
机构
[1] Howard Hughes Medical Institute,
[2] The Sidney Kimmel Comprehensive Cancer Center,undefined
[3] and Program in Cellular and Molecular Medicine,undefined
[4] The Johns Hopkins University Medical Institutions,undefined
来源
Nature | 2004年 / 428卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Arising from: Li, M. et al. Nature416, 648–653 (2002) Ubiquitination of p53 is the principal mechanism through which p53 concentrations in the cell are regulated1,2 in order to maintain its effects on tumori-genesis and normal cell growth. The protein HAUSP (also known as USP7) is a ubiquitin-specific protease (deubiquitinase)3,4 that has been shown by Li et al. to bind to p53 (ref. 5); in overexpression experiments, Li et al. showed that p53 could be stabilized as a result of deubiquitination by HAUSP and suggested that HAUSP may thereby act as a tumour suppressor5,6. Here we use a different approach to investigate the relationship between HAUSP and p53 stability, in which we disrupt the HAUSP gene in human cells by targeted homologous recombination. Instead of the expected increase in ubiquitinated p53 and destabilization of p53, we find that disruption of HAUSP results in the opposite phenotype, leading to stabilization and functional activation of p53 in our system. It may be that HAUSP can deubiquitinate other proteins such as MDM2, another regulator of p53, and that the balance between the deubiquitination of the different targets of HAUSP determines the steady-state level of p53.
引用
收藏
页码:1 / 2
页数:1
相关论文
共 50 条
  • [1] Disruption of HAUSP gene stabilizes p53
    Cummins, JM
    Rago, C
    Kohli, M
    Kinzler, KW
    Lengauer, C
    Vogelstein, B
    NATURE, 2004, 428 (6982) : 1 - 2
  • [2] The p53–Mdm2–HAUSP complex is involved in p53 stabilization by HAUSP
    C L Brooks
    M Li
    M Hu
    Y Shi
    W Gu
    Oncogene, 2007, 26 : 7262 - 7266
  • [3] HAUSP is required for p53 destabilization
    Cummins, JM
    Vogelstein, B
    CELL CYCLE, 2004, 3 (06) : 689 - 692
  • [4] The p53-Mdm2-HAUSP complex is involved in p53 stabilization by HAUSP
    Brooks, C. L.
    Li, M.
    Hu, M.
    Shi, Y.
    Gu, W.
    ONCOGENE, 2007, 26 (51) : 7262 - 7266
  • [5] Deubiquitination of p53 by HAUSP is an important pathway for p53 stabilization
    Li, MY
    Chen, DL
    Shiloh, A
    Luo, JY
    Nikolaev, AY
    Qin, J
    Gu, W
    NATURE, 2002, 416 (6881) : 648 - 653
  • [6] Deubiquitination of p53 by HAUSP is an important pathway for p53 stabilization
    Muyang Li
    Delin Chen
    Ariel Shiloh
    Jianyuan Luo
    Anatoly Y. Nikolaev
    Jun Qin
    Wei Gu
    Nature, 2002, 416 : 648 - 653
  • [7] Inactivation of HAUSP in vivo modulates p53 function
    N Kon
    Y Kobayashi
    M Li
    C L Brooks
    T Ludwig
    W Gu
    Oncogene, 2010, 29 : 1270 - 1279
  • [8] Inactivation of HAUSP in vivo modulates p53 function
    Kon, N.
    Kobayashi, Y.
    Li, M.
    Brooks, C. L.
    Ludwig, T.
    Gu, W.
    ONCOGENE, 2010, 29 (09) : 1270 - 1279
  • [9] Targeting HAUSP in both p53 wildtype and p53-mutant tumors
    Tavana, Omid
    Sun, Hongbin
    Gu, Wei
    CELL CYCLE, 2018, 17 (07) : 823 - 828
  • [10] Small-molecule inhibitor of USP7/HAUSP ubiquitin protease stabilizes and activates p53 in cells
    Colland, Frederic
    Formstecher, Etienne
    Jacq, Xavier
    Reverdy, Celine
    Planquette, Cecile
    Conrath, Susan
    Trouplin, Virginie
    Bianchi, Julie
    Aushev, Vasily N.
    Camonis, Jacques
    Calabrese, Alessandra
    Borg-Capra, Catherine
    Sippl, Wolfgang
    Collura, Vincent
    Boissy, Guillaume
    Rain, Jean-Christophe
    Guedat, Philippe
    Delansorne, Remi
    Daviet, Laurent
    MOLECULAR CANCER THERAPEUTICS, 2009, 8 (08) : 2286 - 2295